Search

Your search keyword '"Abu-Basha, Ehab"' showing total 47 results
Start Over Author "Abu-Basha, Ehab"
47 results on '"Abu-Basha, Ehab"'

3. Author Correction: Predicting the potential for zoonotic transmission and host associations for novel viruses

Author

Pandit, Pranav S., Anthony, Simon J., Goldstein, Tracey, Olival, Kevin J., Doyle, Megan M., Gardner, Nicole R., Bird, Brian, Smith, Woutrina, Wolking, David, Gilardi, Kirsten, Monagin, Corina, Kelly, Terra, Uhart, Marcela M., Epstein, Jonathan H., Machalaba, Catherine, Rostal, Melinda K., Dawson, Patrick, Hagan, Emily, Sullivan, Ava, Li, Hongying, Chmura, Aleksei A., Latinne, Alice, Lange, Christian, O’Rourke, Tammie, Olson, Sarah, Keatts, Lucy, Mendoza, A. Patricia, Perez, Alberto, de Paula, Cátia Dejuste, Zimmerman, Dawn, Valitutto, Marc, LeBreton, Matthew, McIver, David, Islam, Ariful, Duong, Veasna, Mouiche, Moctar, Shi, Zhengli, Mulembakani, Prime, Kumakamba, Charles, Ali, Mohamed, Kebede, Nigatu, Tamoufe, Ubald, Bel-Nono, Samuel, Camara, Alpha, Pamungkas, Joko, Coulibaly, Kalpy J., Abu-Basha, Ehab, Kamau, Joseph, Silithammavong, Soubanh, Desmond, James, Hughes, Tom, Shiilegdamba, Enkhtuvshin, Aung, Ohnmar, Karmacharya, Dibesh, Nziza, Julius, Ndiaye, Daouda, Gbakima, Aiah, sajali, Zikankuba, Wacharapluesadee, Supaporn, Robles, Erika Alandia, Ssebide, Benard, Suzán, Gerardo, Aguirre, Luis F., Solorio, Monica R., Dhole, Tapan N., Nga, Nguyen T. T., Hitchens, Peta L., Joly, Damien O., Saylors, Karen, Fine, Amanda, Murray, Suzan, Karesh, William B., Daszak, Peter, Mazet, Jonna A. K., and Johnson, Christine K.

Published
2023
Full Text
View/download PDF

4. Predicting the potential for zoonotic transmission and host associations for novel viruses

Author

Pandit, Pranav S, Anthony, Simon J, Goldstein, Tracey, Olival, Kevin J, Doyle, Megan M, Gardner, Nicole R, Bird, Brian, Smith, Woutrina, Wolking, David, Gilardi, Kirsten, Monagin, Corina, Kelly, Terra, Uhart, Marcela M, Epstein, Jonathan H, Machalaba, Catherine, Rostal, Melinda K, Dawson, Patrick, Hagan, Emily, Sullivan, Ava, Li, Hongying, Chmura, Aleksei A, Latinne, Alice, Lange, Christian, O’Rourke, Tammie, Olson, Sarah, Keatts, Lucy, Mendoza, A Patricia, Perez, Alberto, de Paula, Cátia Dejuste, Zimmerman, Dawn, Valitutto, Marc, LeBreton, Matthew, McIver, David, Islam, Ariful, Duong, Veasna, Mouiche, Moctar, Shi, Zhengli, Mulembakani, Prime, Kumakamba, Charles, Ali, Mohamed, Kebede, Nigatu, Tamoufe, Ubald, Bel-Nono, Samuel, Camara, Alpha, Pamungkas, Joko, Coulibaly, Kalpy J, Abu-Basha, Ehab, Kamau, Joseph, Silithammavong, Soubanh, Desmond, James, Hughes, Tom, Shiilegdamba, Enkhtuvshin, Aung, Ohnmar, Karmacharya, Dibesh, Nziza, Julius, Ndiaye, Daouda, Gbakima, Aiah, Sajali, Zikankuba, Wacharapluesadee, Supaporn, Robles, Erika Alandia, Ssebide, Benard, Suzán, Gerardo, Aguirre, Luis F, Solorio, Monica R, Dhole, Tapan N, Nga, Nguyen TT, Hitchens, Peta L, Joly, Damien O, Saylors, Karen, Fine, Amanda, Murray, Suzan, Karesh, William B, Daszak, Peter, Mazet, Jonna AK, and Johnson, Christine K

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Infectious Diseases, 2.2 Factors relating to the physical environment, 2.1 Biological and endogenous factors, Infection, Africa, Animals, Animals, Wild, Host Specificity, Humans, Viruses, Zoonoses, PREDICT Consortium, Biological sciences, Biomedical and clinical sciences
Abstract

Host-virus associations have co-evolved under ecological and evolutionary selection pressures that shape cross-species transmission and spillover to humans. Observed virus-host associations provide relevant context for newly discovered wildlife viruses to assess knowledge gaps in host-range and estimate pathways for potential human infection. Using models to predict virus-host networks, we predicted the likelihood of humans as hosts for 513 newly discovered viruses detected by large-scale wildlife surveillance at high-risk animal-human interfaces in Africa, Asia, and Latin America. Predictions indicated that novel coronaviruses are likely to infect a greater number of host species than viruses from other families. Our models further characterize novel viruses through prioritization scores and directly inform surveillance targets to identify host ranges for newly discovered viruses.

Published
2022

5. Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018

Author

Holloway, Peter, Gibson, Matthew, van Doremalen, Neeltje, Nash, Stephen, Holloway, Tanja, Letko, Michael, Cardwell, Jacqueline M., Al Omari, Bilal, Al-Majali, Ahmad, Abu-Basha, Ehab, Mangtani, Punam, Munster, Vincent J., and Guitian, Javier

Subjects
Communicable diseases in animals -- Statistics -- Risk factors, Camels -- Statistics -- Health aspects, Health
Abstract

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) represents 1 of 3 major zoonotic coronaviruses to have emerged with global impact in the past 2 decades, alongside severe acute respiratory syndrome [...]

Published
2021
Full Text
View/download PDF

12. Predicting the potential for zoonotic transmission and host associations for novel viruses

Author

Pandit, Pranav, primary, Anthony, Simon, additional, Goldstein, Tracey, additional, Olival, Kevin, additional, Doyle, Megan, additional, Gardner, Nicole, additional, Bird, Brian, additional, Smith, Woutrina, additional, Wolking, David, additional, Gilardi, Kristen, additional, Monagin, Corina, additional, Kelly, Terra, additional, Uhart, Marcela, additional, Epstein, Jonathan, additional, Machalaba, Catherine, additional, Rostal, Melinda, additional, Dawson, Patrick, additional, Hagan, Emily, additional, Sullivan, Ava, additional, Li, Hongying, additional, Chmura, Aleksei, additional, Latinne, Alice, additional, Lange, Christian, additional, O'Rourke, Tammie, additional, Olson, Sarah, additional, Keatts, Lucy, additional, Mendoza, A. Patricia, additional, Perez, Alberto, additional, de Paula, Catia Dejuste, additional, Zimmerman, Dawn, additional, Valitutto, Marc, additional, LeBreton, Matthew, additional, McIver, David, additional, Islam, Ariful, additional, Duong, Veasna, additional, Mouiche, Moctar, additional, Shi, Zheng-Li, additional, Mulembakani, Prime, additional, Kumakamba, Charles, additional, Ali, Mohamed, additional, Kebede, Nigatu, additional, Tamoufe, Ubald, additional, Bel-Nono, Samuel, additional, Camara, Alpha, additional, Pamungkas, Joko, additional, Coulibaly, Julien Kalpy, additional, Abu-Basha, Ehab, additional, Kamau, Joseph, additional, Silithammavong, Soubanh, additional, Desmond, James, additional, Hughes, Tom, additional, Shiilegdamba, Enkhtuvshin, additional, Aung, Ohnmar, additional, Karmacharya, Dibesh, additional, Nziza, Julius, additional, Ndiaye, Daouda, additional, Gbakima, Aiah, additional, Sijali, Zikankuba, additional, Wacharapluesadee, Supaporn, additional, Robles, Erika Alandia, additional, Ssebide, Benard, additional, Suzán, Gerardo, additional, Aguirre, Luis, additional, Solorio, Monica, additional, Dhole, Tapan, additional, Hitchens, Peta, additional, Joly, Damien, additional, Saylors, Karen, additional, Fine, Amanda, additional, Murray, Suzan, additional, Karesh, William, additional, Daszak, Peter, additional, Mazet, Jonna, additional, Consortium, PREDICT, additional, and Johnson, Christine, additional

Published
2022
Full Text
View/download PDF

14. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses

Author

Abu-Basha, Ehab A, Bani Ismail, Zuhair, Ababneh, Mohammed M, Hamzeh, Eyad, Gehring, Ronette, IRAS OH Pharmacology, dIRAS RA-1, IRAS OH Pharmacology, and dIRAS RA-1

Subjects
040301 veterinary sciences, Cmax, Administration, Oral, Biological Availability, 0403 veterinary science, Subcutaneous injection, Animal science, Pharmacokinetics, bacterial pneumonia, In vivo, Medicine, Animals, Horses, Respiratory system, tildipirosin, equine, Pharmacology, Volume of distribution, General Veterinary, business.industry, 0402 animal and dairy science, Respiratory infection, macrolide, 04 agricultural and veterinary sciences, 040201 dairy & animal science, Bioavailability, Area Under Curve, Injections, Intravenous, adverse effects, Tylosin, business, pharmacokinetics
Abstract

Tildipirosin is a semi-synthetic macrolide antibiotic commonly used in cattle and swine to treat bacterial pneumonia. The objective of this study was to investigate the pharmacokinetic profile of tildipirosin after a single intravenous (i.v.) and subcutaneous (s.c.) administration in healthy lambs. Eighteen lambs were randomly divided into three groups (n = 6 each). Lambs received a single s.c. dose of tildipirosin at 4 and 6 mg/kg b.w. in group 1 and 2, respectively. Lambs in group 3 received a single i.v. dose of tildipirosin at 4 mg/kg b.w. Blood samples were collected at 0, 0.5, 0.75, 1.5, 2, 3, 4, 6, 8, 10, 24, 36, 48 hr, and every 24 hr to day 21, and thereafter at day 28 posttildipirosin administration. The plasma concentrations of tildipirosin were determined using high-performance liquid chromatography with tandem mass spectrometry detection (LC⁄MS⁄MS). All lambs appeared to tolerate both the intravenous and subcutaneous injection of tildipirosin. Following i.v. administration, the elimination half-life (T1/2 ), mean residence time (MRT), volume of distribution (Vd/F), and total body clearance (Cl/F) were 119.6 ± 9.0 hr, 281.9 ± 25.7 hr, 521.1 ± 107.2 L, and 2.9 ± 0.5 L/hr, respectively. No significant differences in Cmax (657.0 ± 142.8 and 754.6 ± 227.1 ng/ml), Tmax (1.21 ± 0.38 and 1.35 ± 0.44 hr), T1/2 (144 ± 17.5, 156.5 ± 33.4 hr), and MRT (262.0 ± 30.2 and 250.6 ± 54.5 hr) were found in tildipirosin after s.c. dosing at 4 and 6 mg/kg b.w., respectively. The absolute bioavailability (F) of tildipirosin was 71.5% and 75.3% after s.c. administration of 4 and 6 mg/kg b.w., respectively. In conclusion, tildipirosin was rapidly absorbed and slowly eliminated after a single s.c. administration in healthy lambs. Tildipirosin could be used for the treatment and prevention of respiratory bacterial infections in sheep. However, further in vitro and in vivo studies to determine the efficacy and safety are warranted. To our knowledge, this is the first study to determine the tildipirosin pharmacokinetic parameters in sheep plasma.

Published
2021

15. Socializing One Health: an innovative strategy to investigate social and behavioral risks of emerging viral threats

Author

Saylors, Karen, Wolking, David J., Hagan, Emily, Martinez, Stephanie, Francisco, Leilani, Euren, Jason, Olson, Sarah H., Miller, Maureen, Fine, Amanda E., Thanh, Nga Nguyen Thi, Tran Minh, Phuc, Kalengkongan, Jusuf D., Kusumaningrum, Tina, Latinne, Alice, Pamungkas, Joko, Safari, Dodi, Saputro, Suryo, Bamba, Djeneba, Coulibaly, Kalpy Julien, Dosso, Mireille, Laudisoit, Anne, N'guettia Jean, Kouassi Manzan, Dutta, Shusmita, Islam, Ariful, Shano, Shahanaj, Mwanzalila, Mwokozi I., Trupin, Ian P., Gbakima, Aiah, Bangura, James, Yondah, Sylvester T., Karmacharya, Dibesh, Shrestha, Rima D., Kamta, Marcelle Annie Matsida, Mouiche, Mohamed Moctar Mouliom, Ndolo, Hilarion Moukala, Niama, Fabien Roch, Onikrotin, Dionne, Daszak, Peter, Johnson, Christine K., Mazet, Jonna A. K., Abaneh, Ola, Ababneh, Mustafa, Rafia, Jum, Sukor, Abd, Abdullah, Mohd Lufti, Abedin, Josefina, Abu-Basha, Ehab, Ali, Mohamed, Beal Akoundze, Junior, Akpaki, Joel, Al Hanandeh, Sief Addeen, Al Omari, Bilal, Al Shakil, Abdullah, Al-Zghoul, Mohammed, Albart, Stephenie Ann, Alshammari, Abdullah, Amarneh, Basil H., Ampofo, William, Andrew, Victoria, Ahn, Dao Le, Ankhanbaatar, Ulaankhuu, Anthony, Simon, Antonjaya, Ungke, Araya, Kidan, Arku, Jallah, Arshat, Norsharina, Asigbee, Theodore, Aung, Ohnmar, Awuni, Joseph, Ayukebong, James, Azian, Mohammed, Aziz, Nor Adilah, Ba, Aminata, Bassan, Ganzorig, Bagato, Ola, Bamba, Aboubacar, Bamba, Djenba, Barkhasbaatar, Ariunbaatar, Barrera, June, Basaraba, Cale, Bel-nono, Samuel, Belaganahalli, Manjunatha, Belay, Desalgen, Belkharia, Jaber, Binol, Ridzki M. F., Bird, Brian, Bista, Manisha, Biswas, Pitu, Blake, Matthew, Boatemaa, Linda, Bonason, Margret, Brandful, James, Brown, Joseph, Brownstein, John, Camara, Mamadi, Camara, Salif, Chai, Daniel, Chakraborty, Debapriyo, Chale, Hannah, Chaudhary, Ashok, Chea, Sokha, Chmura, Aleksei, Goossens, Benoit, Chow, Andrew, Churchill, Carolina, Commey, Abraham, Couacy-Hymann, Emmanuel, Coulibaly, Julien Kalpy, Cranfield, Michael, Damanik, Wirda, Damdinjav, Batchullum, Danial, Norhidayah, Dasak, Peter, David, Runie, Dawson, Patrick, Dembele, Arjouma, Deme, Awa, Desmond, James, Dewantari, Arghianditya Kresno, Dhanota, Jaseet, Dhole, Tapan, Diep, Nguyen Thi, Dionkounda, Artistide, Diop, Gaye Laye, Dodd, Kimberly, Dogby, Otilia, Dorjnyam, Tumendemberel, Dosso, Mireielle, Doumbouya, Kalil, Doumbouya, Mohamed Idriss, Doyle, Megan, Dramou, Simone, Drazenovich, Tracy, Duc Ahn, Dang, Duc Luu, Bach, Duendkae, Prateep, Duoc, Vu Trong, Duong, Tran Nhu, Duong, Veasna, Dursman, Huda, Dussart, Phillipe, Ee, Tan Jun, Ekiri, Abel, El Rifay, Amira S., El Shesheny, Rabel, El Taween, Ahmed N., Emmanuel, Zena Babu, Epstein, Jonathan H., Evans, Tierra Smiley, Fahmawi, Alaa, Fahn, Simeon, Feferholtz, Yasha, Ferdous, Jinnat, Fine, Amanda, Flora, Meerjady, Fransisco, Leilani, Fui Fui, Lem, Gabourie, Taylor, Gani, Millawati, Garbo, Michael, Gardner, Nicole, Gbamele, Marie, Ge, Xingyi, Gee, Lee Heng, Genovese, Brooke, Gibson, Alexandra, Gilardi, Kirsten, Gilbert, Martin, Gillis, Amethyst, Ginsos, Andrew, Godji Gnabro, Privat, Goldstein, Tracey, Gomaa, Moktar, Gomis, Jules, Gonzalez, Kevin, Grange, Zoe, Greig, Denise, Grodus, Michael, Gueu, Kpon Kakeuma Romeo, Gutierrez, Leticia, Haba, Dan Marcelin, Hamid, Suraya, Harris, Daniel K., Hashim, Abdul Kadir Abu, Hassan, Moushumi, Hassan, Quazar Nizamuddin, He, Qun, Hemachudha, Thiravat, Henry, Helen, Herbert, Ronald, Hijazeen, Zaidoun, Hilarion, Moukala Ndolo, Hill, Rebecca, Hoa, Nguyen Thi, Horwood, Paul, Hossain, Md. Enayet, Hossain, Saddam, Htun, Moh Moh, Hu, Ben, Hughes, Tom, Hul, Vibol, Van, Vo, Hussein, Fatima, Indola, Ghislain Dzeret, Iskandriati, Diah, Islam, Md. Tarikul, Islam, Shariful, Isnaim Ismail, Mohd, Ismail, Zuhair Bani, Iyanya, Jacques, Jaimin, Joel Judson, Jambai, Amara, Japning, Jeffrine Rovie Ryan, Japrin, Alexter, Jean Louis, Frantz, Joe, Titus, Johnson, Erica, Joly, Damien, Joshi, Jyotsna, Kalengkongan, Jusuf, Kalivogui, Douokoro, Kamara-Chieyoe, Nenneh, Kamau, Joseph, Kambale Syaluha, Eddy, Kandeil, Ahmed, Kane, Yogouba, Karesh, William, Kargo, Kandeh, Kasenda, Novie, Kayali, Ghazi, Kayed, Ahmed S., Kazwala, Rudovick, Ke, Changwen, Keates, Lucy, Kebede, Nigatu, Khamphaphongphane, Bouaphanh, Kheong, Chong Chee, Kilonzo, Christopher, Koffa, Ma-Sue, Kollie, Amos G., Kondiano, Marcel Sidik, Koropo, Michel, Kouamé Kouakou, Valere, Kouassi Koffi, Eugene, Kourouma, Mariam, Koutate, Abdoulaye Ousmane, Kowel, Citra Liv, Krou, Hermann Assemien, Kumakamba, Charles, Kutkat, Omnia, Lamah, François, Lan, Nguyen Thi, Lane, Jennifer, Lange, Christian, Larmouth, Emmanuel, Le Doux, Joseph Diffo, Leasure, Elizabeth, Leasure, Katherine, LeBreton, Mat, Lee, Jimmy, Lee, Helen, Lee, Mei Ho, Leno, Amara, Li, Hongying, Liang, Eliza, Liang, Neal, Lim, Dorothy, Lipkin, W. Ian, Liu, Jun, Lo, Modou Moustafa, Lojivis, Leonoris, Long, Nguyen Van, Lucas, Ashley, Lukusa, Jean Paul, Lungay, Victor, Lushima, Shongo, Lutwama, Julius, Ma, Wenjun, Machalaba, Catherine, Maganga, Grace, Magesa, Walter Simon, Mahmoud, Sara H., Makuwa, Maria, Makweta, Asha, Mamun, Abdullah Al, Manandhar, Prajwol, Maneeorn, Patarapol, Mann, Harjeet, Maomy, Bhele, Maptue, Victorine, Mathew, Alice, Mavoungou, Yanne Vanessa, Maw, Min Thein, Mazet, Jonna, Mbala, Placide, Mbuba, Emmanuel, Mbunwe, Eric, McIver, David, Mendelsohn, Emma, Miegakanda, Valchy Bel-Bebi, Minh, Phan Quang, Mkali, Happy, Moatasim, Yassmin, Mombouli, Jean Vivien, Monagin, Corina, Montecino-Latorre, Diego, Mossoun Mossoun, Arsene, Mostafa, Ahmed, Mouiche, Moctar, Mpassi, Romain Bagamboula, Msigwa, Alphonce, Mudakikwa, Antoine, Mugok, Laura Benedict, Mulembakani, Prime, Murray, Suzan, Musa, Fakhrul Hatta, Musabimana, Pacifique, Mutura, Samson, Mwamlima, Tunu, Mwanzanilla, Mwokozi, Myaing, Tin Tin, Myat, Theingi Win, Myo Chit, Aung, N’faly, Magassouba, N’Guettia, Manzan Jean, N’télo, Anatole, Nakimera, Sylivia, Nam, Vu Sinh, Napit, Rajindra, Nathan, Senthilvel K. S. S., Navarrete-Macias, Isamara, Ndebe, Kortu M., Ndiaye, Amadou, Ndiaye, Daouda, Negash, Yohannes, Nga, Nguyen Thi Thanh, Ngay, Ipos, Ngoc, Pham Thi Bich, Niama, Fabien, Nina, Rock Aimé, Niyonzima, Schadrack, Nkom, Felix, Nkoua, Cynthia, Noordin, Noorliza, Noviana, Rachmitasari, Nwobegahay, Julius, Nziza, Julius, O’Rourke, Daniel, O’Rourke, Tammie, Obodai, Evangeline, Okello Okwir, Ricky, Olival, Kevin, Olson, Sarah, Olva, Onkirotin Dionne, Ontiveros, Victoria, Opook, Fernandes, Panchadcharam, Chandrawathani, Pandit, Pranav, Parra, Henri-Joseph, Phuc, Tran Minh, Phuong, Nguyen Thanh, Poultolnor, Jackson Y., Pradhan, Saman, Preston, Eunah Cho, Pruvot, Mathieu, Purevtseren, Dulam, Puri, Dhiraj, Quang, Le Tin Vinh, Rachmitasari, Novie, Rahman, Kaisar, Rahman, Mizanur, Rahman, Mohammed Ziaur, Rahman, Mustafizur, Ramirez, Diana, Randhawa, Nistara, Raut, Samita, Rosario, Joseph, Ross, Albert, Ross, Noam, Rostal, Melinda, Roualdes, Pamela, Rubin, Eddy, Rumi, Aftab Uddin, Rundi, Christina, Sackie, Melkor, Sajali, Zikankuba, Samuels, Sandra G, Sango, Mathias, Saptu, Ammar Rafidah, Saraka, Daniel N’guessan, Sartee, Alvis A., Sayandouno, Sia Alida, Seck, Mame Cheikh, Sedor, Victoria, Sharma, Ajay Narayan, Sharminie, Velsri, Shehata, Mahmoud M., Sheikh, Gafur, Shi, Zhengli, Shiilegdamba, Enkhtuvshin, Shrestha, Bishwo, Shrestha, Rima, Sidibey, Mohammed, Silithammavong, Soubanh, Simon, Daniel, Sion, Emilly, Sipangkui, Symphorosa, Sitam, Frankie Thomas, Smith, Brett, Smith, Bridgette, Smith, Woutrina, Sodnom, Batsikhan, Ssebide, Benard, Suleiman, Maria, Sullivan, Ava, Sungif, Nur Amirah, Suu-Ire, Richard, Sy, Mouhamed, Takuo, Jean Michel, Talafha, Hani, Tamoufe, Ubald, Tetteh, Emmanuel, Than Toe, Aung, Thanda, Lanash, Thanh Long, Ngo, Thein, Wai Zin, Theppangna, Watthana, Thinh, Nguyen Duc, Thuy, Hoang Bich, Thuy, Nguyen Thu, Togami, Eri, Tolno, Moise Bendoua, Tolovou, Kevin, Topani, Rahmat, Tremeau-Bravard, Alexandre, Trupin, Ian, Tumushime, Jean Claude, Tun, Kyaw Yan Naing, Turay, Joseph, Uddin, Helal, Uhart, Marcela, Ureda, Nicole, Valitutto, Marc, Verasahib, Khebir, Vodzak, Megan, Wacharapluesadee, Supaporn, Wahad, Mohammad Yuery Wazlan Abdul, Watson, Brooke, Wells, Heather, White, Allison, Willoughby, Anna, Wiyatno, Ageng, Wolking, David, Yang, Xinglou, Yao, Lim Ming, Yombouno, Sayon, Young, Cristin, Zambrana-Torrelio, Carlos, Zeid, Zahidah Izzati, Zghoul, Ghadeer, Zhang, Libiao, Zhang, Yunzhi, Zhu, Guangjian, Zimmerman, Dawn, Zoumarou, Daba, Aguirre, Alonso, Aguirre, Luis, Akongo, Mark-Joel, Alandia Robles, Erika, Ambu, Laurentius, Ayala Aguilar, Glenda, Barcena, Luis, Barradas, Rosario, Basir, Misliah Mohamad, Bogich, Tiffany, Bounga, Gerard, Buchy, Philippe, Bunn, David, Byaruba, Denis, Cameron, Ken, Carroll, Dennis, Cavero, Nancy, Cespedes, Manuel, Che, Xiaoyu, Chiu, Charles, Chor, Kimashalen, Clements, Andrew, Dary Acevedo, Luz, de Almeida Campos, Angelica, De La Puente, Micaela, de Lamballerie, Xavier, de Paula, Catia, Delwart, Eric, Diffo Le Doux, Joseph, Doyle-Capitman, Catherine, Durigon, Edison, Fair, Joseph, Ferrer-Paris, José R., Formenty, Pierre, Galarza, Isabel, Garcia, Joel, Grard, Gilda, Greatorex, Zoe, Harris, Laurie, Hitchens, Peta, Ho, Mei, Hosseini, Parviez, In, Samath, Iñíguez, Volga, Jain, Komal, Jamaluddin, Abd. Aziz, Johnson, Christine, Jones, Kate, Joyner, Priscilla, Kaba, Serge, Kambale, Eddy, Kataregga, Abdulhameed, Kelly, Terra, Khammavong, Kongsy, Kilpatrick, A. Marm, Laimun, Samsir, Lee, Mei-Ho, LeRoy, Eric, Levinson, Jordan, Levy, Marc, Limachi, Rolando, Loh, Elizabeth, Lowenstine, Linda J., Luis Mollericona, José, Maganga, Ruth, Malakalinga, Joseph, Manhas, Melissa, Marra, Pete, Mbabazi, Rachael, Medellín, Rodrigo, Mendoza, Patricia, Miller, Sireeda, Miranda, Flavia, Mitchell, Megan, Mohamed, Ramlan, Mollard, Debbie, Morse, Stephen, Mouellet, Wivine, Moya, Isabel, Murillo, Yovanna, Murray, Kris, Muyembe Tamfum, Jean-Jacques, Nassar, Fernando, Nathan, Sen, Nsengimana, Olivier, Ogg Keatts, Lucy, Ojeda-Flore, Rafael, Okwir Okello, Ricky, Ondzie, Alain, Paweska, Janusz, Pereira, Alisa, Pereira, Victoria, Perez, Alberto, Perez, Jocelyn, Phon, Simorn, Reed, Patricia, Rejmanek, Dan, Rico, Oscar, Rivera, Rosario, Romero, Monica, Roy, Celina, Saepuloh, Uus, Schneider, Brad, Schwind, Jessica, Singhalath, Sinpakhome, Smith, Kristine, Suárez, Fabiola, Suzan, Gerardo, Thanh Nga, Nguyen Thi, Thomas, Kate, Ticona, Herminio, VanWormer, Elizabeth, Villar, Sandra, Weisman, Wendy, Westfall, Michael, Whittier, Chris, Wicker, Leanne, Wolfe, Nathan, Yang, Angela, Zariquiey, Carlos, Zhang, Shu-Yi, Zorine Nkouants, Baudelaire, Zainuddin, Zainal, Chrisman, Cara, Pabst, August, Shek, Amalhin, and Trostle, Murray

Subjects
0301 basic medicine, Behavioral risk, medicine.medical_specialty, Behavioural sciences, Disease, Community integration, Basic Behavioral and Social Science, 03 medical and health sciences, 0302 clinical medicine, Clinical Research, 2.3 Psychological, Behavioral and Social Science, Agency (sociology), medicine, 2.2 Factors relating to the physical environment, GE1-350, Aetiology, One health, Social science research, business.industry, Prevention, Research, Public health, PREDICT Consortium, Public relations, Focus group, Environmental sciences, Good Health and Well Being, 030104 developmental biology, One Health, Multi-disciplinary surveillance, social and economic factors, Public aspects of medicine, RA1-1270, Infection, Psychology, International development, business, 030217 neurology & neurosurgery
Abstract

In an effort to strengthen global capacity to prevent, detect, and control infectious diseases in animals and people, the United States Agency for International Development’s (USAID) Emerging Pandemic Threats (EPT) PREDICT project funded development of regional, national, and local One Health capacities for early disease detection, rapid response, disease control, and risk reduction. From the outset, the EPT approach was inclusive of social science research methods designed to understand the contexts and behaviors of communities living and working at human-animal-environment interfaces considered high-risk for virus emergence. Using qualitative and quantitative approaches, PREDICT behavioral research aimed to identify and assess a range of socio-cultural behaviors that could be influential in zoonotic disease emergence, amplification, and transmission. This broad approach to behavioral risk characterization enabled us to identify and characterize human activities that could be linked to the transmission dynamics of new and emerging viruses. This paper provides a discussion of implementation of a social science approach within a zoonotic surveillance framework. We conducted in-depth ethnographic interviews and focus groups to better understand the individual- and community-level knowledge, attitudes, and practices that potentially put participants at risk for zoonotic disease transmission from the animals they live and work with, across 6 interface domains. When we asked highly-exposed individuals (ie. bushmeat hunters, wildlife or guano farmers) about the risk they perceived in their occupational activities, most did not perceive it to be risky, whether because it was normalized by years (or generations) of doing such an activity, or due to lack of information about potential risks. Integrating the social sciences allows investigations of the specific human activities that are hypothesized to drive disease emergence, amplification, and transmission, in order to better substantiate behavioral disease drivers, along with the social dimensions of infection and transmission dynamics. Understanding these dynamics is critical to achieving health security--the protection from threats to health-- which requires investments in both collective and individual health security. Involving behavioral sciences into zoonotic disease surveillance allowed us to push toward fuller community integration and engagement and toward dialogue and implementation of recommendations for disease prevention and improved health security. Supplementary Information The online version contains supplementary material available at 10.1186/s42522-021-00036-9.

Published
2021

19. Limited Genetic Diversity Detected in Middle East Respiratory Syndrome-Related Coronavirus Variants Circulating in Dromedary Camels in Jordan

Author

Seifert, Stephanie N., primary, Schulz, Jonathan E., additional, Ricklefs, Stacy, additional, Letko, Michael, additional, Yabba, Elangeni, additional, Hijazeen, Zaidoun S., additional, Holloway, Peter, additional, Al-Omari, Bilal, additional, Talafha, Hani A., additional, Tibbo, Markos, additional, Adney, Danielle R., additional, Guitian, Javier, additional, Amarin, Nadim, additional, Richt, Juergen A., additional, McDowell, Chester, additional, Steel, John, additional, Abu-Basha, Ehab A., additional, Al-Majali, Ahmad M., additional, van Doremalen, Neeltje, additional, and Munster, Vincent J., additional

Published
2021
Full Text
View/download PDF

20. Experiences in Delivering Teaching and Learning Practices in Establishments of Veterinary Education of the Mediterranean Region Under COVID-19 Pandemic: From Crisis to Opportunities.

Author

FEJZIC, Nihad, SERIC-HARACIC, Sabina, AYAZ, Naim Deniz, DE MENEGHI, Daniele, ABU BASHA, Ehab, TLIGUI, Noursaid, ETTRIQUI, Abdelfettah, GATTA, Pier PAOLO, SANS, Pierre, LEBLOND, Agnès, SOUBEYRAN, Emmanuelle, DEGUEURCE, Christophe, RIPANI, Alessandro, BOUGUEDOUR, Rachid, and PARODI, André-Laurent

Subjects
CORONAVIRUS diseases, VETERINARY students, VETERINARY medicine, VETERINARY teachers
Abstract

In this study, the impact of coronavirus disease 2019 pandemic crisis on veterinary education in selected members of the Mediterranean Network of Veterinary Education Establishments (Bosnia and Herzegovina, France, Italy, Turkey, Jordan, Morocco, and Tunis) was analyzed. The challenges presented by the pandemic and new approaches and practices adopted by different veterinary education establishments in the Mediterranean region to address the long-term consequences of coronavirus disease 2019 on veterinary education were highlighted. Although countries in this region followed different epidemiological policies, restrictions of access of veterinary students to teaching hospitals, extramural facilities, and laboratories were prolonged over the entire time during 2020 and 2021 in most of the veterinary education establishments. It could be concluded that strengthening the existing networks of veterinary education establishments in the region by sharing experiences, standardization of curricula (regional and international accreditation), and networking are seen as an opportunity for improvement of the quality of teaching and competence in this digital era. Unfortunately, more work is still required to achieve such an ambitious agenda including galvanization of public demands for quality education, political will to implement changes, and securing financial support and other resources to continue program development across the region. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

25. Comparative pharmacokinetics and bioavailability of two tylosin formulations in chickens after oral administration

Author

ABU-BASHA, EHAB A, AL-SHUNNAQ, AHMAD F., and GEHRING, RONETTE

Subjects
φαρμακοκινητική, chicken, βιοδιαθεσιμότητα, tylsoin, τυλοσίνη, κοτόπουλο, bioavailability, pharmacokinetics
Abstract

Η φαρμακοκινητική και βιοδιαθεσιμότητα δύο σκευασμάτων τυλοσίνης χορηγούμενων από το στόμα πραγματοποιήθηκε σε κοτόπουλα κρεατοπαραγωγής με την μέθοδο απλής δόσης, τυχαιοποιημένου και παράλληλου σχεδιασμού. Τα δύο σκευάσματα της τυλοσίνης (Tylosina® και Tylan®) χορηγήθηκαν από το στόμα σε δόση 25 mg/kg σ.β. μετά από νηστεία μιας βραδιάς (n=15 κοτόπουλα/ομάδα). Για τον υπολογισμό της βιοδιαθεσιμότητας της τυλοσίνης, δεκαπέντε επιπλέον κοτόπουλα ορίστηκαν ως ομάδα 3 και τους χορηγήθηκε μια απλή ενδοφλέβια δόση τυλοσίνης 25 mg/kg σ.β. Δείγματα αίματος συλλέχθηκαν σε διάφορους χρόνους μέχρι και 24 ώρες μετά τη χορήγηση του φαρμάκου. Η μέθοδος της υγροχρωματογραφίας υψηλής απόδοσης (HPLC) χρησιμοποιήθηκε για τον προσδιορισμό των συγκεντρώσεων της τυλοσίνης στο πλάσμα. Η φαρμακοκινητική ανάλυση των δεδομένων πραγματοποιήθηκε χρησιμοποιώντας την ανάλυση του μη διαμερισματικού προτύπου με τη στατιστική θεωρεία στιγμής και τη βοήθεια εμπορικά διαθέσιμου υπολογιστικού προγράμματος (WinNonlin®, Pharsight Corporation, Cary, NC, USA). Δεν υπήρχαν σημαντικές διαφορές στην τιμή Cmax (3.05±0.63, 2.63±0.74 μg/ml), tmax (2.36±0.42, 2.30±0.38 h), t1/2β (1.99±0.38, 2.67±0.60 h), AUC0-12h (6.11±0.97, 5.37±1.16 μg.h/ml), AUC0-∞ (6.38±0.94, 5.57±1.15 μg.h/ml), MRT (3.53±0.24, 3.67±0.32 h), ClB/F (90.59±13.81, 169.38±54.44 ml/min/kg) και Vdz/F (16.85±4.74, 43.96±18.24 l/kg) μεταξύ των σκευασμάτων Tylosina® και Tylan®, αντίστοιχα. Η υπολογισμένη βιοδιαθεσιμότητα (F) από το στόμα ήταν 40,56 και 35,41%, αντίστοιχα. Επιπλέον, η σχετική βιοδιαθεσιμότητα του Tylosina® ήταν 113,9% σε σχέση με το Tylan®. Συμπερασματικά, το σκεύασμα Tylosina® είναι συγκρίσιμο με το σκεύασμα Tylan® και αμφότερα τα σκευάσματα μπορούν να χρησιμοποιηθούν για την αντιμετώπιση ευαίσθητων μικροοργανισμών στην κτηνιατρική πράξη σε δόση 25 mg/kg σ.β., The pharmacokinetics and oral bioavailability of two tylosin formulations was carried out in broiler chickens according to a single dose, randomized, parallel design. The two formulations of tylosin (Tylosina® and Tylan®) were given orally at a dose level of 25 mg/kg b.w. after an overnight fasting (n=15 chicken/group). To calculate tylosin bioavailability, fifteen more chickens was assigned as group 3 and was given a single intravenous dose of tylosin (25 mg/kg b.w.). Serial blood samples were collected at different time points up to 24 hour post-drug administration. A high performance liquid chromatography (HPLC) method was used for the determination of tylosin concentrations in chicken plasma. The pharmacokinetics analysis of the data was performed using non-compartmental analysis based on statistical moment theory with the help of commercially available software (WinNonlin®, Pharsight Corporation, Cary, NC, USA). There were no significant differences in the Cmax (3.05±0.63, 2.63±0.74 μg/ml), tmax (2.36±0.42, 2.30±0.38 h), t1/2β (1.99±0.38, 2.67±0.60 h), AUC0-12h (6.11±0.97, 5.37±1.16 μg.h/ml), AUC0-∞ (6.38±0.94, 5.57±1.15 μg.h/ml), MRT (3.53±0.24, 3.67±0.32 h), ClB/F (90.59±13.81, 169.38±54.44 ml/min/kg) and Vdz/F (16.85±4.74, 43.96±18.24 l/kg) between Tylosina® and Tylan®, respectively. The calculated oral bioavailability (F) for Tylosina® and Tylan® were 40.56 and 35.41%, respectively. Moreover, the relative bioavailability of Tylosina® was 113.9% when compared to Tylan®. In conclusion, Tylosina® is comparable to Tylan® and both formulations can be used for treatment of susceptible microorganisms in veterinary medicine practice at a dose level of 25 mg/kg b.w.

Published
2017

26. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep.

Author

Abu‐Basha, Ehab A., Bani Ismail, Zuhair, Abu Alhaijaa, Hind, Hamzeh, Eyad, and Idkaidek, Nasir M.

Subjects
*TANDEM mass spectrometry, *BIOAVAILABILITY, *LIQUID chromatography-mass spectrometry, *INTRAVENOUS therapy, *SHEEP, *HIGH performance liquid chromatography, *PHARMACOKINETICS, *MACROLIDE antibiotics
Abstract

Tildipirosin is a semi‐synthetic macrolide antibiotic commonly used in cattle and swine to treat bacterial pneumonia. The objective of this study was to investigate the pharmacokinetic profile of tildipirosin after a single intravenous (i.v.) and subcutaneous (s.c.) administration in healthy lambs. Eighteen lambs were randomly divided into three groups (n = 6 each). Lambs received a single s.c. dose of tildipirosin at 4 and 6 mg/kg b.w. in group 1 and 2, respectively. Lambs in group 3 received a single i.v. dose of tildipirosin at 4 mg/kg b.w. Blood samples were collected at 0, 0.5, 0.75, 1.5, 2, 3, 4, 6, 8, 10, 24, 36, 48 hr, and every 24 hr to day 21, and thereafter at day 28 posttildipirosin administration. The plasma concentrations of tildipirosin were determined using high‐performance liquid chromatography with tandem mass spectrometry detection (LC⁄MS⁄MS). All lambs appeared to tolerate both the intravenous and subcutaneous injection of tildipirosin. Following i.v. administration, the elimination half‐life (T1/2), mean residence time (MRT), volume of distribution (Vd/F), and total body clearance (Cl/F) were 119.6 ± 9.0 hr, 281.9 ± 25.7 hr, 521.1 ± 107.2 L, and 2.9 ± 0.5 L/hr, respectively. No significant differences in Cmax (657.0 ± 142.8 and 754.6 ± 227.1 ng/ml), Tmax (1.21 ± 0.38 and 1.35 ± 0.44 hr), T1/2 (144 ± 17.5, 156.5 ± 33.4 hr), and MRT (262.0 ± 30.2 and 250.6 ± 54.5 hr) were found in tildipirosin after s.c. dosing at 4 and 6 mg/kg b.w., respectively. The absolute bioavailability (F) of tildipirosin was 71.5% and 75.3% after s.c. administration of 4 and 6 mg/kg b.w., respectively. In conclusion, tildipirosin was rapidly absorbed and slowly eliminated after a single s.c. administration in healthy lambs. Tildipirosin could be used for the treatment and prevention of respiratory bacterial infections in sheep. However, further in vitro and in vivo studies to determine the efficacy and safety are warranted. To our knowledge, this is the first study to determine the tildipirosin pharmacokinetic parameters in sheep plasma. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

29. High Prevalence of Middle East Respiratory Coronavirus in Young Dromedary Camels in Jordan

Author

van Doremalen, Neeltje, primary, Hijazeen, Zaidoun S.K., additional, Holloway, Peter, additional, Al Omari, Bilal, additional, McDowell, Chester, additional, Adney, Danielle, additional, Talafha, Hani A., additional, Guitian, Javier, additional, Steel, John, additional, Amarin, Nadim, additional, Tibbo, Markos, additional, Abu-Basha, Ehab, additional, Al-Majali, Ahmad M., additional, Munster, Vincent J., additional, and Richt, Juergen A., additional

Published
2017
Full Text
View/download PDF

33. Twin fetal maceration in a cow associated with persistent corpus luteum and closed cervix

Author

Hailat, Nabil, Lafi, Shawkat, Al-Sahli, Ayman, Abu-Basha, Ehab, and Fathalla, Mahmound

Subjects
Fetus, Fetal death, business.industry, Uterus, Maceration (bone), Physiology, medicine.anatomical_structure, embryonic structures, Medicine, Gestation, Closed cervix, business, Corpus luteum, Cervix
Abstract

Fetal maceration in the cow that occurs after the third month of gestation, when fetal bones are fairly well developed, and that may be caused by wound infection type bacterial agents, especially Corynobacterium pyogenes, progressing to septic metritis with death and maceration of the fetus in a closed uterus, is uncommon. In other circumstances, fetal death with maceration in cattle is usually accompanied by regression of the corpus luteum (CL) with opened cervix. In two previous surveys, in which we studied the gross lesions ofbovine reproductive tracts, we did not encounter any case of fetal maceration. This report provides macroscopic description of a case of twin fetal maceration in the cow associated with persistent corpus luteum and closed cervix., The Bovine Practitioner, No. 30 (1996 May)

Published
1996
Full Text
View/download PDF

42. Effect of chronic lead intoxication on the distribution and elimination of amoxicillin in goats.

Author

Soliman, Ahmed M., Abu-Basha, Ehab A., Youssef, Salah A. H., Amer, Aziza M., Murphy, Patricia A., Hauck, Catherine C., Gehring, Ronette, and Hsu, Walter H.

Subjects
LEAD toxicology, AMOXICILLIN, GOATS, PHARMACOKINETICS, BLOOD serum analysis, TRANSFERASES, ANIMAL health
Abstract

A study of amoxicillin pharmacokinetics was conducted in healthy goats and goats with chronic lead intoxication. The intoxicated goats had increased serum concentrations of liver enzymes (alanine aminotransferase and γ-glutamyl transferase), blood urea nitrogen, and reactivated δ-aminolevulinic acid dehydratase compared to the controls. Following intravenous amoxicillin (10 mg/kg bw) in control and lead-intoxicated goats, elimination half-lives were 4.14 and 1.26 h, respectively. The volumes of distribution based on the terminal phase were 1.19 and 0.38 L/kg, respectively, and those at steady-state were 0.54 and 0.18 L/kg, respectively. After intramuscular (IM) amoxicillin (10 mg/kg bw) in lead-intoxicated goats and control animals, the absorption, distribution, and elimination of the drug were more rapid in lead-intoxicated goats than the controls. Peak serum concentrations of 21.89 and 12.19 μg/mL were achieved at 1 h and 2 h, respectively, in lead-intoxicated and control goats. Amoxicillin bioavailability in the lead-intoxicated goats decreased 20% compared to the controls. After amoxicillin, more of the drug was excreted in the urine from lead-intoxicated goats than the controls. Our results suggested that lead intoxication in goats increases the rate of amoxicillin absorption after IM administration and distribution and elimination. Thus, lead intoxication may impair the therapeutic effectiveness of amoxicillin. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

45. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses.

Author

Abu-Basha EA, Bani Ismail Z, Ababneh MM, Hamzeh E, and Gehring R

Subjects
Administration, Oral, Animals, Area Under Curve, Biological Availability, Horses, Injections, Intravenous veterinary, Tylosin analogs & derivatives
Abstract

This study was designed to investigate the safety and pharmacokinetic (PK) profile of tildipirosin in horses after intravenous (i.v.) and subcutaneous (s.c.) injection of a single dose at 4 mg/kg of body weight (b.w.). A total of 12 healthy mixed breed horses were used in the study. Horses were monitored for systemic and local adverse effects, and whole blood samples were collected for hematology and plasma biochemistry analysis at time (0) and at 6, 24, and 72 h after drug administration. For PK analysis, blood samples were collected at pre-determined times before and after tildipirosin administration. Plasma concentrations of tildipirosin were determined using ultra-high-performance liquid chromatography-ultraviolet detection method (UHPLC-UV). All horses tolerated the i.v. injection of tildipirosin without showing any systemic adverse effects. However, a non-painful, soft swelling appeared at the s.c. injection site in 5 horses (41.7%). On average, tildipirosin reached a maximum plasma concentration (C max ) of 1257 ng/ml (geometric mean) between 0.5 and 1.5 h after s.c. administration (T max ). The geometric mean values for total body clearance (Cl), the apparent volume of distribution based on the terminal phase (V z ), and the apparent volume of distribution at steady-state (V ss ) were 0.52 L/kg·h, 22 L/kg, and 10.0 L/kg, respectively. Data collected in this study suggests that tildipirosin can be used safely in horses with caution., (© 2021 John Wiley & Sons Ltd.)

Published
2021
Full Text
View/download PDF

46. In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens.

Author

Tarazi YH, Abu-Basha EA, Ismail ZB, and Tailony RA

Abstract

Background and Aim: At present, there are no data about the efficacy of some recent antibiotics on Escherichia coli in broiler chickens in the study area. This study was designed to evaluate the in vitro and in vivo efficacy of cefepime, doripenem, tigecycline, and tetracycline against multidrug-resistant-extended-spectrum beta-lactamases (MDR-ESBLs) producing E. coli in broiler chicks., Materials and Methods: A total of 34 MDR-ESBLs E. coli isolates were used in this study. In vitro evaluation of the antibacterial efficacy of cefepime, doripenem, tigecycline, and tetracycline were performed using disk diffusion and minimum inhibitory concentration (MIC) assays. In vivo evaluation of the efficacy of the antibiotics was perfumed using 180, 2-week-old chicks challenged with MDR-ESBL-producing E. coli strain O78. Chicks were divided into six groups (30 chicks each) according to the treatment regimen. Treatment was administered to chicks in Groups 3-6 intravenously, twice per day for 1 week using one antibiotic per group at concentration 10 times the determined MIC. Chicks in the positive control (Group 1) were challenged and received 0.2 ml of sterile Tryptone Soy Broth (TSB), while those in the negative control (Group 2) were not challenged and received 0.2 ml of sterile TSB. The severity of clinical signs, gross lesions, and mortality rate was scored and compared between groups., Results: All E. coli isolates were sensitive to doripenem and tigecycline, while 88% were sensitive to cefepime and only 23% were sensitive to tetracycline. In vivo antibiotic efficacy evaluation in challenged chicks revealed a significant reduction in the severity of clinical signs, gross lesions, and mortality (3%) in chicks treated with cefepime compared to non-treated chicks (55%). There was no significant effect on the severity of clinical signs, gross lesions, and mortality in chicks treated with doripenem, tigecycline, and tetracycline compared to non-treated chicks. The mortality rates of chicks treated with doripenem, tigecycline, and tetracycline were 57%, 50%, and 90%, respectively., Conclusion: The results of this study indicate that most MDR-ESBLs producing E. coli isolates were sensitive to doripenem, tigecycline, and cefepime. However, in vivo study indicated that only cefepime was effective and resulted in a significant reduction in clinical signs, gross lesions, and mortality in infected chicks. Therefore, cefepime could be used to treat naturally infected chickens with MDR-ESBLs producing strains of E. coli ., (Copyright: © Tarazi, et al.)

Published
2020
Full Text
View/download PDF

47. High Prevalence of Middle East Respiratory Coronavirus in Young Dromedary Camels in Jordan.

Author

van Doremalen N, Hijazeen ZS, Holloway P, Al Omari B, McDowell C, Adney D, Talafha HA, Guitian J, Steel J, Amarin N, Tibbo M, Abu-Basha E, Al-Majali AM, Munster VJ, and Richt JA

Subjects
Aging, Animals, Cattle, Cattle Diseases epidemiology, Cattle Diseases virology, Coronavirus Infections epidemiology, Coronavirus Infections virology, Jordan epidemiology, Prevalence, RNA, Viral genetics, Seroepidemiologic Studies, Sheep, Sheep Diseases epidemiology, Sheep Diseases virology, Virus Shedding, Camelus virology, Coronavirus Infections veterinary, Middle East Respiratory Syndrome Coronavirus isolation & purification
Abstract

Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) was determined in 45 dromedary camels from two geographically separated herds in Jordan. Virus shedding was only detected in swabs obtained from the respiratory tract and primarily observed in camels younger than 3 years. MERS-CoV seroprevalence increased with age of camels. Bovine and sheep sera were seronegative. Phylogenetic analysis of partial S2 clustered the Jordanian MERS-CoV strains with contemporary MERS-CoV strains associated with nosocomial outbreaks., Competing Interests: Author Disclosure Statement No competing financial interests exist.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results